Navigation Links
Research and Development Forecast of China's Coronary Stent Industry, 2013-2017
Date:12/5/2013

London (PRWEB) December 05, 2013

In 2008, China finished more than 180,000 PCI surgical cases (percutaneous coronary intervention); the stent system which was used in PCI surgeries also increased to 298,000 sets in 2008 from 40,000 sets in 2002 as for the usage quantity. Since 2011, the increasingly fierce market competition has decelerated the stent system growth rate. In 2012, the usage quantity of coronary stent was about 633,600 sets and the market scale reached CNY 3.15 billion.

According to the data from the Ministry of Health, China Customs, Surgical Instrument Professional Committee of China Association for Medical Devices Industry, Chinese Society of Cardiology and some other professional associations, Huidian Research released “Research and Development Forecast of China’s Coronary Stent Industry, 2013-2017”, which mainly analyzes the market scale, demand status, competitive landscape, business performance and market share of key enterprises; on this basis, this report also provides professional investment opportunity and risk analysis, as well as scientific development prospect of the coronary stent industry.

The characteristic of this report is the summary and detailed analysis on the latest industry policy, measures and specific implementation, which can help you understanding the industry policy environment completely.

1. Overview of Coronary Stent Industry
1.1 Definition
1.2 Classification and Application
1.3 Structure of Industry Chain

2. Overview of Global Coronary Stent Market
2.1 Development Overview
2.1.1 Technical Development
2.1.2 Market Progress
2.2 Coronary Stent Market in Major Countries
2.2.1 The United States
2.2.2 Germany
2.2.3 Japan
2.3 Development Trend, 2013-2017

3. External Environment of China’s Coronary Stent Industry
3.1 China’s Macroeconomic Environment
3.1.1 Economic Development Status
3.1.2 GDP
3.1.3 Investment in the Fixed Assets
3.1.4 Total Export-Import Volume and the Growth Rate
3.2 Policy Environment
3.2.1 National Related Policies
3.2.2 Main Supervision Standards, Laws and Regulations
3.2.3 Comment on Policy Measure Implementation

4. Overall Development Status of China’s Coronary Stent Industry, 2012
4.1 Development Overview
4.1.1 Product Characteristics
4.1.2 Pricing Mechanisms
4.1.3 Marketing Channel
4.1.4 Promotion Method
4.2 Development Status
4.3 Product Price
4.3.1 Price Review, 2009-2012
4.3.2 Price Trend, 2013-2017
4.3.3 Factors Affecting the Price and the Coping Strategy
4.4 Competitive Landscape
4.4.1 Domestic Enterprises Occupy the Leading Position
4.4.2 Gaps between Domestic Enterprises and Foreign Large-scale Enterprises
4.5 Business Model

5. Import and Export of China’s Coronary Stent Industry, 2010-2012
5.1 Sources of Import and Destinations of Export
5.2 Import and Export Data, 2012
5.2.1 Import Volume
5.2.2 Import Price
5.2.3 Export Volume
5.2.4 Export Price
5.3 Forecast of Import and Export, 2013-2017
5.3.1 Import Forecast
5.3.2 Export Forecast

6. Influence of Upstream and Downstream Development on Coronary Stent Industry
6.1 Upstream Industries
6.2 Downstream User Market

7. Key Enterprises in Coronary Stent Industry
7.1 Boston Scientific
7.1.1 Company Profile
7.1.2 Business Performance
7.1.3 Competitiveness
7.1.4 Development Strategy
7.2 Medtronic
7.2.1 Company Profile
7.2.2 Business Performance
7.2.3 Mergers and Acquisitions
7.2.4 Development Strategy
7.3 Abbott
7.3.1 Company Profile
7.3.2 Business Performance
7.3.3 Competitiveness
7.3.4 Channel Development Strategy
7.4 MicroPort
7.4.1 Company Profile
7.4.2 Business Performance
7.4.3 Competitiveness
7.4.4 Development Strategy
7.5 Lepu Medical
7.5.1 Company Profile
7.5.2 Business Performance
7.5.3 Main Business
7.5.4 Competitiveness
7.5.5 Development Strategy
7.6 JW Medical Systems
7.6.1 Company Profile
7.6.2 Product Advantage
7.6.3 Business Performance
7.6.4 Scientific Research Status
7.6.5 Development Planning

8. Investment Opportunity, Value and Suggestion
8.1 Investment Opportunity
8.1.1 Balance between Supply and Demand
8.1.2 Industry Merging and Reorganization Trend
8.1.3 New Projects
8.2 Product Investment Value
8.3 Barriers to Entry
8.3.1 Technology and Process Barriers
8.3.2 Talent Barriers
8.3.3 Patent Barriers
8.3.4 Policy Barriers
8.3.5 Market Channel Barriers
8.4 Average Revenue Level
8.5 Investment Risk

9. Integrated Forecasting and Prospect of Coronary Stent, 2013-2017
9.1 Market Scale and Sales Forecast
9.2 Interpretation of Related Contents in the “Twelfth Five-Year” Plan
9.3 Conclusion and Suggestion from Experts

Companies Mentioned

Boston Scientific
Medtronic
Abbott
MicroPort
Lepu Medical
JW Medical Systems

Read the full report:

Research and Development Forecast of China's Coronary Stent Industry, 2013-2017

http://www.reportbuyer.com/business_government/misc_business_services/research_development_forecast_china_s_coronary_stent_industry_2013_2017.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Research_and_Development

For more information:
Sarah Smith
Research Advisor at Reportbuyer.com
Email: query@reportbuyer.com
Tel: +44 208 816 85 48
Website: http://www.reportbuyer.com

Read the full story at http://www.prweb.com/releases/2013/12/prweb11397137.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. UAlberta researchers uncover why combination drug treatment ineffective in cancer clinical trials
2. Researchers identify fundamental differences between human cancers and genetically engineered mouse models of cancer
3. UEA researchers receive share of £1.26 million to reduce animal experimentation for drug development
4. Oncology Leads Biosimilars Market Growth to 2018 Forecasts in New Research Report at RnRMarketResearch.com
5. California College of Ayurveda Announces the Publication of New Research In Collaboration with UC Davis Dermatology Department on the Herb Gotu Kola
6. UCSB researcher finds origin of inherited gene mutation causing early-onset Alzheimers
7. BUSM professor receives award for Alzheimers research
8. Research on China’s Animal Vaccine Industry, 2013-2017
9. Research and Development Trend of China Independent Clinical Laboratory Market, 2013-2017
10. End-Year Special Offer on Research Studies by Current Partnering Now Available at MarketPublishers.com
11. mHealth Market to Post 32.3% CAGR Through 2020, States Allied Market Research in Its Report Published at MarketPublishers.com
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... ... ... PawPaws brand pet supplements owned by Whole Health Supply is ... of felines. The formula is all-natural and is made from Chinese herbs that have ... Kidney Support Supplement Soft Chews are Astragalus Root Extract and Rehmannia Root Extract ...
(Date:6/25/2016)... , ... June 25, 2016 , ... ... policy issues and applications at AcademyHealth’s Annual Research Meeting June 26-28, 2016, at ... on several important health care topics including advance care planning, healthcare costs and ...
(Date:6/25/2016)... (PRWEB) , ... June 25, 2016 , ... "With 30 ... their specific project," said Christina Austin - CEO of Pixel Film Studios. , ... and all within Final Cut Pro X . Simply select a ProHand generator ...
(Date:6/25/2016)... ... June 25, 2016 , ... Dr. ... from injury. Recently, he has implemented orthobiologic procedures as a method for treating ... one of the first doctors to perform the treatment. Orthobiologics are substances that ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... A recent ... that most people are unfamiliar with. The article goes on to state that individuals ... also many of these less common operations such as calf and cheek reduction. The ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)...   Pulmatrix, Inc ., (NASDAQ: PULM ... announced today that it was added to the Russell ... comprehensive set of U.S. and global equity indexes on ... milestone for Pulmatrix," said Chief Executive Officer Robert ... progress in developing drugs for crucial unmet medical needs, ...
(Date:6/23/2016)... Research and Markets has announced the addition of ... report to their offering. ... kidney failure, it replaces the function of kidneys by removing ... thus the treatment helps to keep the patient body,s electrolytes ... Increasing number of ESRD patients & substantial healthcare expenditure ...
(Date:6/23/2016)... , June 23, 2016 Roche (SIX: ... 510(k) clearance for its Elecsys BRAHMS PCT (procalcitonin) assay ... sepsis or septic shock. With this clearance, Roche is ... a fully integrated solution for sepsis risk assessment and ... with bacterial infection and PCT levels in blood can ...
Breaking Medicine Technology: